Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.48 |
| ▸ | HMGCR | P04035 | 3/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL141442 | 1.00 | PTPN7 (0.48) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL135615 | 0.97 | PTPN7 (0.45) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL7199135 | 0.90 | — | — | |
| SCHEMBL2973182 | 0.84 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL2971217 | 0.84 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL2971333 | 0.84 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL2965662 | 0.84 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL2975852 | 0.84 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL2969743 | 0.84 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1MEN1 | |
| SCHEMBL2964415 | 0.84 | PTPN7 (0.52) | PTPN7HMGCRRECQLTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3223952-B1 | ENERGY INPUT DURING AGGLOMERATION FOR MAGNETIC SEPARATION | BASF SE (DE) | 2024-01-17 | — | — | EP | disclosed |
| EP-4301520-A1 | MAGNETIC SEPARATION OF PARTICLES SUPPORTED BY SPECIFIC SURFACTANTS | BASF SE (DE) | 2024-01-10 | — | — | EP | disclosed |
| CN-116438009-A | Particle magnetic separation assisted by specific surfactants | 巴斯夫欧洲公司 | 2023-07-14 | — | — | CN | disclosed |
| WO-2022184817-A1 | MAGNETIC SEPARATION OF PARTICLES SUPPORTED BY SPECIFIC SURFACTANTS | BASF SE (DE) | 2022-09-09 | — | — | WO | disclosed |
| US-11110468-B2 | Separation of a mixture using magnetic carrier particles | BASF SE (DE) | 2021-09-07 | — | — | US | disclosed |
| US-10807100-B2 | Concentrate quality | BASF SE (DE) | 2020-10-20 | — | — | US | disclosed |
| US-10799881-B2 | Energy input during agglomeration for magnetic separation | BASF SE (DE) | 2020-10-13 | — | — | US | disclosed |
| EP-3661652-A1 | SEPARATION OF A MIXTURE USING MAGNETIC CARRIER PARTICLES | BASF SE (DE) | 2020-06-10 | — | — | EP | disclosed |
| US-20200122160-A1 | SEPARATION OF A MIXTURE USING MAGNETIC CARRIER PARTICLES | BASF SE (DE) | 2020-04-23 | — | — | US | disclosed |
| US-10549287-B2 | Ultraflotation with magnetically responsive carrier particles | BASF SE (DE) | 2020-02-04 | — | — | US | disclosed |
| US-20120058463-A1 | HYDROPHOBIC, FUNCTIONALIZED PARTICLES | SIEMENS AG (DE) | 2012-03-08 | — | — | US | disclosed |
| EP-0389162-B1 | 2,5,6,7-Tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES (JP) | 1993-12-08 | — | — | EP | disclosed |
| EP-0274064-B1 | 2,5,6,7-TETRANOR-18,18,19,19-TETRADEHYDRO-4,8-INTER-M-PHENYLENE PGI2 DERIVATIVES | TORAY INDUSTRIES, INC. (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-5086071-A | Improved chemical stability and ppotent in vivo | TORAY INDUSTRIES, INC. (JP) | 1992-02-04 | — | — | US | disclosed |
| EP-0232776-B1 | 2,5,6,7-TETRANOR-4,8-INTER-M-PHENYLENE PGI2 DERIVATIVES | TORAY INDUSTRIES, INC. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0389162-A1 | 2,5,6,7-Tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES, INC. (JP) | 1990-09-26 | — | — | EP | disclosed |
| US-4880939-A | ANTISECRETORY AGENTS, HYPOTENSIVES, ANTICOAGULANTS | TORAY INDUSTRIES (JP) | 1989-11-14 | — | — | US | disclosed |
| US-4775692-A | ANTILIPEMIC, ANTICOAGULANT, HYPOTENSIVE, ANTISECRETORY AND ANTIULCER AGENT | TORAY INDUSTRIES, INC. (JP) | 1988-10-04 | — | — | US | disclosed |
| EP-0274064-A2 | 2,5,6,7-Tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES, INC. (JP) | 1988-07-13 | — | — | EP | disclosed |
| EP-0232776-A2 | 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES, INC. (JP) | 1987-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058463-A1 | HYDROPHOBIC, FUNCTIONALIZED PARTICLES | CD44, CD40LG, EPCAM | PTPN7 2791/4885HMGCR 2822/4885RECQL 2006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.